These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 33350234)
1. [Effect of ginsenoside Rg_3 nanostructured lipid carrier modified by pullulan on promoting absorption and its anti-tumor evaluation in vitro]. Qing Y; Ning C; Dao-Biao C; Xin J Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(21):5184-5192. PubMed ID: 33350234 [TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid-coated nanostructured lipid carriers for loading multiple traditional Chinese medicine components for liver cancer treatment. Sun S; Guan Q; Shang E; Xiao H; Yu X; Shi L; Zhao C; Guo Y; Lv S; Li Y Pak J Pharm Sci; 2020 Jan; 33(1):109-119. PubMed ID: 32122838 [TBL] [Abstract][Full Text] [Related]
6. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Liu D; Liu Z; Wang L; Zhang C; Zhang N Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845 [TBL] [Abstract][Full Text] [Related]
7. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. Li H; Chen M; Su Z; Sun M; Ping Q Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421 [TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of photo-responsive cell-penetrating peptide-mediated nanostructured lipid carrier. Yang Y; Yang Y; Xie X; Cai X; Mei X J Drug Target; 2014 Dec; 22(10):891-900. PubMed ID: 25045925 [TBL] [Abstract][Full Text] [Related]
9. Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics in treatment of psoriasis: a comparative study. Arora R; Katiyar SS; Kushwah V; Jain S Expert Opin Drug Deliv; 2017 Feb; 14(2):165-177. PubMed ID: 27882780 [TBL] [Abstract][Full Text] [Related]
10. Improved anti-obesity effect of herbal active and endogenous lipids co-loaded lipid nanocarriers: Preparation, in vitro and in vivo evaluation. Lacatusu I; Badea N; Udeanu D; Coc L; Pop A; Cioates Negut C; Tanase C; Stan R; Meghea A Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():12-24. PubMed ID: 30889655 [TBL] [Abstract][Full Text] [Related]
11. Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells. Zhou J; Sun M; Jin S; Fan L; Zhu W; Sui X; Cao L; Yang C; Han C Drug Deliv; 2019 Dec; 26(1):281-289. PubMed ID: 30880491 [TBL] [Abstract][Full Text] [Related]
12. [Preparation of isopsoralen loaded nanostructured carrier and its in vitro transdermal permeation characteristics]. Pang JY; Liu X; Shen BD; Shen CY; Lian WQ; Liu J; Hu CX; Zhong RN; Xu RC; Yuan HL Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2473-2478. PubMed ID: 28840686 [TBL] [Abstract][Full Text] [Related]
13. [Ginsenoside Rg_3 based liposomes target delivery of dihydroartemisinin and paclitaxel for treatment of triple-negative breast cancer]. Liu H; Liu Y; Li N; Zhang GQ; Wang M Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(13):3472-3484. PubMed ID: 37474984 [TBL] [Abstract][Full Text] [Related]
14. PEGylated long circulating nanostructured lipid carriers for Amoitone B: preparation, cytotoxicity and intracellular uptake. Luan J; Yang X; Chu L; Xi Y; Zhai G J Colloid Interface Sci; 2014 Aug; 428():49-56. PubMed ID: 24910034 [TBL] [Abstract][Full Text] [Related]
15. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema. Gao S; Tian B; Han J; Zhang J; Shi Y; Lv Q; Li K Int J Nanomedicine; 2019; 14():6135-6150. PubMed ID: 31447556 [No Abstract] [Full Text] [Related]
16. Nanostructured Lipid Carriers (NLC) as Vehicles for Topical Administration of Sesamol: In Vitro Percutaneous Absorption Study and Evaluation of Antioxidant Activity. Puglia C; Lauro MR; Offerta A; Crascì L; Micicchè L; Panico AM; Bonina F; Puglisi G Planta Med; 2017 Mar; 83(5):398-404. PubMed ID: 27124246 [TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of PEGylated asiatic acid nanostructured lipid carriers on anti-fibrosis effects. Chen X; Zhang Y; Zhao P; Chen Y; Zhou Y; Wang S; Yin L Drug Dev Ind Pharm; 2020 Jan; 46(1):57-69. PubMed ID: 31813288 [TBL] [Abstract][Full Text] [Related]
18. Alpha-lipoic acid-loaded nanostructured lipid carrier: sustained release and biocompatibility to HaCaT cells in vitro. Wang J; Xia Q Drug Deliv; 2014 Aug; 21(5):328-41. PubMed ID: 24144220 [TBL] [Abstract][Full Text] [Related]
19. A comparative study on the efficiency of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan surface modified nanostructured lipid carrier for ophthalmic delivery of curcumin. Li J; Liu D; Tan G; Zhao Z; Yang X; Pan W Carbohydr Polym; 2016 Aug; 146():435-44. PubMed ID: 27112894 [TBL] [Abstract][Full Text] [Related]
20. [Preparation of podophyllotoxin nanostructured lipid carriers and its effects on immortalized human cervical epithelial cells with HPV infection in vitro]. Chong SB; Zeng K; Li GF; Ren F; Zhu XL; Zhou JJ Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(6):1023-8. PubMed ID: 21690061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]